Current Assets Endring Dato
Abbott USD 23.51B 872M 2023-06
Accelerate Diagnostics USD 32.44M 9.8M 2023-09
Agilent USD 4.34B 152M 2023-12
Atrion USD 115.74M 266K 2023-09
Avanos Medical USD 524.6M 17.7M 2023-09
Becton, Dickinson and Co. USD 8.16B 520M 2023-12
Bruker USD 2.16B 135.6M 2023-12
Catalent USD 2.57B 44M 2023-12
Charles River Laboratories USD 1.61B 164.34M 2023-12
Danaher USD 13.94B 7.27B 2023-12
Exact Sciences USD 1.19B 46.18M 2023-12
Haemonetics USD 764.98M 100.76M 2023-12
Hologic USD 3.49B 690.3M 2023-12
Illumina USD 2.61B 103M 2023-12
IQVIA Holdings USD 5.6B 388M 2023-12
Merit Medical Systems USD 1.11B 523.15M 2023-12
Mettler Toledo International USD 1.23B 33.29M 2023-12
Myriad Genetics USD 313.6M 48.2M 2023-12
Neogen USD 624.37M 40.58M 2023-09
OraSure Technologies USD 356.46M 14.9M 2023-09
Pacific Biosciences Of California USD 882M 53.56M 2023-09
Quidel USD 1.31B 60.8M 2023-12
Revvity USD 3B 87.85M 2023-12
Sientra USD 86.51M 5.4M 2023-09
STAAR Surgical USD 365.27M 18.2M 2023-12
Thermo Fisher Scientific USD 24.59B 1.5B 2023-12
Waters USD 1.63B 46.66M 2023-09



Quidel Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.